Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

Swiss generics and biosimilars drugmaker Sandoz today presented its net-sales performance for the nine months and third ...

US biotech Biogen (Nasdaq: BIIB) reported third-quarter 2025 revenue of $2.5 billion, up 3%, with GAAP diluted EPS of $3.17, ...

Further changes to information published in November 2021 about the government's procurement of PPE during the early months of the COVID-19 pandemic ...

Zink opened the session by recapping key efficacy data for ruxolitinib cream in non-segmental vitiligo from the TRuE-V1/2 ...